Overexpression of ZKSCAN3 enhances CCND2 promoter activity and induces protein expression [94], whereas gene silencing significantly reduces CCND2 levels, which in turn inhibits myeloma cell proliferation [17,63]. The gene discussed is ZKSCAN3; the disease is plasma cell myeloma.